invIOs
Phase 1invIOs is developing NEXT-GENERATION CANCER THERAPEUTICS that empower and educate the immune system to fight cancer.
Founded
2018
Focus
BiologicsRNA & Gene TherapySmall Molecules
About
invIOs is developing NEXT-GENERATION CANCER THERAPEUTICS that empower and educate the immune system to fight cancer.
Funding History
2Total raised: $27.5M
Series A$25MForbionMar 15, 2023
Seed$2.5Maws GründerfondsJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationVienna, Austria
StagePhase 1
Contact
SIMILAR COMPANIES
AlgOss Biotechnologies
Pre-clinical · Graz
Angios Biotech
Pre-clinical ·
F4 Pharma
Pre-clinical · Vienna
aTENSION.life
Pre-clinical · Vienna
Austrianni
Pre-clinical · Vienna
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile